Boston Doctor to be Honored for Clinical Excellence by National Kidney Foundation

Dr. Gary Curhan will receive the Donald W. Seldin Award at NKF’s 2020 Spring Clinical Meetings
New York, NY – November 19, 2019 - Each year the National Kidney Foundation (NKF) considers the work of hundreds of specialists in the field of nephrology and selects among them those who most exemplify the relentless efforts of NKF to enhance the lives of patients through action, education and accelerating change.
Their work is vital to the 37 million adults who are affected by kidney disease and the 1 in 3 Americans who are at risk.
Among the prestigious awards that will be presented at NKF’s 2020 Spring Clinical Meetings in New Orleans, March 25-29, will be the Donald W. Seldin Award to Gary Curhan, MD, from Brigham and Women’s Hospital, Boston.
“I am deeply honored and humbled to have been chosen for the NKF’s Donald Seldin Award,” said Dr. Curhan. “Dr. Seldin was a role model as he was not only a ‘triple-threat’ with an impressive knowledge of clinical medicine, an engaging approach to teaching, and important research contributions, but he was also recognized as an outstanding mentor. These are all qualities that I strive for as part of my academic career. It is particularly meaningful as I will receive the award from one of my previous mentees, Dr. Holly Kramer, the current President of NKF.”
The Seldin award was established to recognize excellence in clinical nephrology in the tradition of one of the foremost teachers and researchers in the field.
“Dr. Curhan exemplifies humanism in his clinical care, teaching, research and mentorship,” said Dr. Holly Kramer, NKF President. “He reminds us that the patients wellbeing and quality of life must be central in everything we do. The Nephrology community is incredibly grateful for all his extended efforts in our field for the past 25 years.” 
His major active research interests include the epidemiology of nephrolithiasis, risk factors for renal function decline, novel risk factors for cardiovascular disease, health effects of analgesic use, novel risk factors for hypertension, and epidemiology of gout.
Dr. Gary Curhan, a clinically active nephrologist, is Professor of Medicine at Harvard Medical School and Professor of Epidemiology at the Harvard TH Chan School of Public Health. He received his MD from Harvard Medical School and his ScD in Epidemiology from the Harvard TH Chan School of Public Health. He completed his residency in Internal Medicine and his Nephrology fellowship at Massachusetts General Hospital.
After serving as the Clinical Chief of Nephrology at the West Roxbury VA Medical Center, he joined the Renal Division at Brigham and Women’s Hospital. Dr. Curhan has been continuously funded by NIH R01 grants for over 25 years.
NKF Spring Clinical Meetings
For the past 28 years, nephrology healthcare professionals from across the country have come to NKF’s Spring Clinical Meetings to learn about the newest developments related to all aspects of nephrology practice; network with colleagues; and present their research findings. The NKF Spring Clinical Meetings are designed for meaningful change in the multidisciplinary healthcare teams’ skills, performance, and patient health outcomes. It is the only conference of its kind that focuses on translating science into practice for the entire healthcare team.  This year’s Spring Clinical Meetings will be held March 25-29 in New Orleans.
NKF Professional Membership
Healthcare professionals can join NKF to receive access to tools and resources for both patients and professionals, discounts on professional education, and access to a network of thousands of individuals who treat patients with kidney disease. 
Kidney Disease Facts
In the United States 37 million adults are estimated to have chronic kidney disease—and most aren’t aware of it.  1 in 3 American adults are at risk for chronic kidney disease.  Risk factors for kidney disease include diabetes, high blood pressure, heart disease, obesity and family history.  People of African American, Hispanic, Native American, Asian or Pacific Islander descent are at increased risk for developing the disease.  African Americans are 3 times more likely than Whites, and Hispanics are nearly 1.5 times more likely than non-Hispanics to develop end stage renal disease (kidney failure).
The National Kidney Foundation (NKF) is the largest, most comprehensive, and longstanding patient-centric organization dedicated to the awareness, prevention, and treatment of kidney disease in the U.S. For more information about NKF, visit